http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1801511-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b262c842f9c7f3c38a61e1f2d892f1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-60
filingDate 1968-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac50d3fbf43c2a1645923191f8dcaeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b6be719916c770dc758c15f02297e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4128fd645a5216c93ca995429faafda
publicationDate 1969-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-1801511-A1
titleOfInvention Process for the preparation of β-tetronic acid derivatives
abstract (A) alpha-Aminoalkylation of alpha-unsubst. beta-tetronic acids by reacting them or their derivs. with aldehydes (esp. formaldehyde) and secondary amines. The aminoalkylation can be carried out with alkylolamines (esp. methylolamines). The alpha-unsubst. beta-tetronic acid starting material can be prepd. by dehalogenating alpha-halo (esp. bromo)-tetronic acid. (B) beta-Tetronic acid Mannich bases of formulae (I) and (II):- (II) where R1 = H, aryl or alkyl R2 = tertiary amino Pharmaceutical adjuvants (especially solubilisers) and pharmaceutical active materials.
priorityDate 1968-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420004286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426283076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18469226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411297104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11513733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414873865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57475673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448379541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415989538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422062388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54690323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860597

Total number of triples: 48.